ThomasNet News Logo
Sign Up | Log In | ThomasNet Home | Promote Your Business

BIO announces presenting companies for annual conference.

Print | 
Email |  Comment   Share  
December 30, 2013 - BIO announced preliminary list of presenting companies for the 16th Annual BIO CEO & Investor Conference to be held Feb 10-11, 2014 in New York City. Presenting companies are hand-selected for event, and consist of mid- to large-cap established public as well as late-stage private companies worldwide. Companies typically have a clinical stage program centered around therapeutics, molecular diagnostics, or a platform technology, as well as upcoming clinical, regulatory, or corporate catalyst.

BIO Announces Presenting Companies for 16th Annual BIO CEO and Investor Conference


Biotechnology Industry Organization
1201 Maryland Ave., SW, Ste. 900
Washington, DC, 20024
USA



Press release date: December 19, 2013

More than 140 Companies Expected to Present Their Story to Top Public and Venture Capital Investors

WASHINGTON--The Biotechnology Industry Organization (BIO) today announced the preliminary list of presenting companies for the 16th Annual BIO CEO & Investor Conference to be held February 10-11, 2014 in New York City. Presenting companies are hand-selected for the event, and consist of a selection of mid- to large-cap established public as well as late-stage private companies from around the globe. These companies typically have a clinical stage program centered around therapeutics, molecular diagnostics or a platform technology, as well as an upcoming clinical, regulatory or corporate catalyst.

“2013 has been a banner year for the biotech sector. We have seen more than 40 biotech IPOs this year alone, 15 of which will be represented through company presentations”

“2013 has been a banner year for the biotech sector. We have seen more than 40 biotech IPOs this year alone, 15 of which will be represented through company presentations,” said BIO president & CEO Jim Greenwood. “The BIO CEO and Investor Conference will allow investors and companies alike to engage amongst their peers and discover how best to take advantage of the current market opportunities for the year ahead.”

The following companies are slated to present at this year’s conference:

Public Companies:

ACADIA Pharmaceuticals
AcelRx Pharmaceuticals
Advanced Cell Technology
Advaxis
Agenus
Alcobra Ltd.
Alexion Pharmaceuticals
Alkermes plc
Allergan
Alnylam Pharmaceuticals
Amarantus Bioscience
Anavex Life Sciences Corp.
Anthera Pharmaceuticals
AntriaBio
Apricus Biosciences
Aradigm Corp.
Arena Pharmaceuticals
Athersys
Auxilium Pharmaceuticals
Avita Medical
Bavarian Nordic A/S
BIND Therapeutics*
Biodel
BioLineRx
Biotie Therapies
Catalyst Pharmaceutical Partners
CEL-SCI Corporation
Cempra
Chimerix*
Cleveland BioLabs
Codexis
Columbia Laboratories
Conatus Pharmaceuticals*
Cyclacel Pharmaceuticals
CytoDyn
Cytokinetics
CytRx Corporation
DARA BioSciences
DURECT Corporation
Epizyme*
Exelixis
FivePrime Therapeutics*
Galectin Therapeutic
Galena Biopharma
GENFIT
GenSpera
GTx
Heat Biologics*
Horizon Pharma
Idera Pharmaceuticals
Ignyta
ImmunoCellular Therapeutics
Immunovaccine
Innovus Pharmaceuticals
Inovio Pharmaceuticals
Intra-Cellular Therapies
Intrexon Corporation*
KaloBios Pharmaceuticals*
Keryx Biopharmaceuticals
La Jolla Pharmaceutical Company
Lexicon Pharmaceuticals
Lpath
Mast Therapeutics
Medigene AG
Merck Serono
Mesoblast
Navidea Biopharmaceuticals
NeoStem
Neuralstem
Newron Pharmaceuticals S.p.A.
Northwest Biotherapeutics
NovaBay Pharmaceuticals
Novelos Therapeutics
OHR Pharmaceutical
OncoMed Pharmaceuticals*
Onconova Therapeutics*
OncoSec Medical
Opexa Therapeutics
Ophthotech*
Oragenics
Orexigen Therapeutics
OvaScience
OXiGENE
PDL BioPharma
Prima BioMed
Prometic LifeSciences
Prosensa
pSiVida
Regado Biosciences*
Relypsa*
ReNeuron Group plc
Repros Therapeutics
Resverlogix
Rexahn Pharmaeuticals
Rigel Pharmaceuticals
RXi Pharmaceuticals
Sanofi
SciClone Pharmaceuticals
Selvita S.A.
SIGA Technologies
Soligenix
Sorrento Therapeutics
Stallergenes
Stem Cell Therapeutics
StemCells Inc.
Stemline Therapeutics*
Swedish Orphan Biovitrum AB
SYGNIS AG
Synergy Pharmaceuticals
Synthetic Biologics
Targacept
Tekmira Pharmaceuticals Corporation
Tetraphase Pharmaceuticals*
TG Therapeutics
The Medicines Company
TiGenix N.V.
Tonix Pharmaceuticals
Transition Therapeutics
TrovaGene
Verastem
ZIOPHARM Oncology

Private Companies:

Aduro Biotech
ALS Therapy Development Institute
Cerecor
CymaBay
Kadmon Corporation
KineMed
MaxCyte
Melinta Therapeutics
Mirna Therapeutics
Pieris AG
Polynoma
Proteon Therapeutics
Q Therapeutics
Sutro Biopharma
Symphogen
Trevena
TxCell SA
XDx
*indicates 2013 IPO

Check back often as new presenters are continuously being added. Companies interested in presenting their story can submit an application here.

In addition to Company Presentations, the conference will host Fireside Chats, Therapeutic Workshops, Business Roundtables and the opportunity to arrange meetings between investors, companies and industry executives via BIO’s One-on-One Partnering™ System.

Qualified institutional and venture investors whose primary activity is direct investment in research and development companies are eligible for complimentary registration. Equity research analysts from investment banking institutions also qualify as investors. Media registration also is complimentary for credentialed members of the media. All registrations are subject to verification of credentials.

BIO is pleased to recognize the leadership provided by the BIO CEO & Investor Conference sponsors including supporting banks Leerink Swann and ROTH Capital Partners, LLC.

About BIO
BIO represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIO produces BIOtechNOW, an online portal and monthly newsletter chronicling “innovations transforming our world.” Subscribe to BIOtechNOW.

Upcoming BIO Events

BIO CEO & Investor Conference
February 10–11, 2014
New York, NY

BIO Asia International Conference
April 8-9, 2014
Tokyo, Japan

World Congress on Industrial Biotechnology
May 12-15, 2014
Philadelphia, PA

BIO International Convention
June 23-26, 2014
San Diego, CA

Livestock Biotech Summit
September 16-18, 2014
Sioux Falls, SD

Contacts
Biotechnology Industry Organization (BIO)
Abigail Hirsch, 1-202-962-9235
ahirsch@bio.org
Web: www.bio.org
Blog: www.biotech-now.org
Twitter: @IAmBiotech

Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



 See related product stories
More .....
 See more product news in:
Services
| Featured Manufacturing Jobs
 Other News from this company:
The Biotechnology Industry Organization and Biominas Brasil to Co-Host First Ever BIO Latin America Conference
Synthetic Biology Breaks New Ground on Renewable Chemicals
Partnering Opens for 2014 BIO International Convention with Record Number of Meetings Expected
2014 BIO International Convention to Highlight Digital Health Through Partnership with the Wireless-Life Sciences Alliance
BIO Encourages EPA to Speed Approvals of New Biofuel Pathways
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-mail this story to a friend
Save Story
Search for suppliers of
Trade Associations


Home  |  My ThomasNet News®  |  Industry Market Trends®  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2014 Thomas Publishing Company. All Rights Reserved.
Terms of Use - Privacy Policy



Error close

Please enter a valid email address